Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: I have a question for all, and I do mean all.....ptsczza
The outstanding shares when edig had it's run was closer to 130 million, not 330 million.
Share
New Message
Please login to post a reply